Medikabazaar on track to achieve Rs 3,000-crore mark in FY27: MD and group CEO

B2B healthcare supply chain platform Medikabazaar has posted a 57 per cent growth in the topline to Rs 592 crore in the first quarter of 2026-27, a top company official said on Monday.

The company is firmly on track to achieve a Rs 3,000 crore topline in FY 2026-27, representing approximately 45% growth over the previous financial year, Medikabazaar managing director & group CEO Dinesh Lodha said in a statement.

The growth in the first quarter in FY27 was driven by the company's integrated healthcare ecosystem, including its rapidly expanding digital business, medical devices, pharmaceuticals, healthcare exports, strategic key accounts, and technology-enabled procurement solutions, Lodha said.